Immunomodulating gene therapy
US11547717B2 · kind B2 · utility
3Cited by
3References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 15, 2018 |
| Grant date | Jan 10, 2023 |
| Priority date | — |
| Expiry date | Jul 18, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to Pompe disease and, in particular, to a methods of treating Pompe disease and to compounds/constructs suitable for use in such methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.